Analogously to the oncogenic potential of MAGEA3/A6 expression in tumors resulting in enhanced proliferation by limiting mTOR-dependent autophagy, a similar role of MAGED2 is conceivable, which is abundantly expressed in many types of cancers [33,34,35,36]. The gene discussed is MAGED2; the disease is cancer.